Miller AA, Wheatly P., Sawyer DA, et al: Pharmacological studies of lamotrigine, a novel potential antiepileptic drug: I. Anticonvulsant profile in mice and rats. Epilepsia1986;27:483-489.
2.
Goa KL, Ross SR, Chrisp P.: Lamotrigine. A review of its pharmacological properties and clinical efficacy in epilepsy. Drugs1992;46:152-176.
3.
Besag FMC, Wallace SJ, Dulac O., et al: Lamotrigine for the treatment of epilepsy in childhood, in: Pediatric Pharmacology and Therapeutics. St. Louis, Mosby-Year Book Inc, 1995 , pp 991-997.
4.
Betts T., Goodwin G., Withers RM, Yuen A.: Human safety of lamotrigine. Epilepsia1991 ;32(Suppl 2):S17-S21.
5.
Messenheimer J., Ramsay RE, Willmore LJ: Lamotrigine therapy for partial seizures: A multicenter, placebo-controlled, double-blind, crossover trial. Epilepsia1994;35:113-121.
6.
Matsuo F., Bergen D., Faught E.: Placebo-controlled study of the efficacy and safety of lamotrigine in patients with partial seizures. Neurology1993;43:2284-2291.
7.
Schapel GJ, Beran RG, Vajda FJE, et al: Double-blind, placebo-controlled, crossover study of lamotrigine in treatment-resistant partial seizures. J Neurol Neurosurg Psychiatry1993;56:448-454.
8.
Sander JW, Trevisol-Bittencourt PC, Hart YM, et al: The efficacy and long-term tolerability of lamotrigine in the treatment of severe epilepsy. Research1990 ;7:226-229.
9.
Schlumberger E., Chavez F., Palacios L., et al: Lamotrigine in treatment of 120 children with epilepsy. Epilepsia1994;35:359-367.
10.
Battino B., Buti D., Croci D., et al: Lamotrigine in resistant childhood epilepsy. Neuropediatrics1993;24:332-336.